Bio-Pharmaceutical Process Monitoring With Real-Time Execution Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The biopharmaceutical industry faces challenges in efficiently and flexibly manufacturing complex products with highly specific requirements, such as large molecule drugs and personalized medicines, which demand tightly controlled and high-quality manufacturing processes.
Innovation Solution
A method and system for monitoring bio-pharmaceutical processes that involve obtaining and executing a set of instructions, providing execution status updates, and forming execution status indications to continuously track the process status, allowing for real-time adjustments and improved process control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional batch manufacturing processes are used for biopharmaceuticals, then manufacturing flexibility is limited, but process control and quality assurance become more difficult
Solution Approach 1:
The patent implements real-time feedback mechanisms through continuous monitoring of process parameters (temperature, pH, dissolved oxygen, flow rates) and automatic adjustment of control variables based on deviations from target profiles. This closed-loop control system maintains process reliability while enabling flexibility through dynamic adaptation to changing manufacturing requirements
Solution Approach 2:
The system transitions from static batch protocols to dynamic continuous processing, where process parameters are continuously adjusted based on real-time sensor data and predictive models. This dynamic approach allows the manufacturing process to adapt to varying product specifications and scale requirements while maintaining consistent quality through automated control
2Adaptability or versatility
If complex personalized medicines are manufactured in smaller scale, then manufacturing flexibility improves, but production efficiency decreases
Solution Approach 1:
The patent describes a universal manufacturing platform that can handle multiple product types and scales through standardized modular equipment and integrated control systems. The same continuous processing line can manufacture both large-volume conventional biologics and small-batch personalized medicines, with the ability to rapidly reconfigure parameters and protocols between different product runs
Solution Approach 2:
The system enables efficient small-scale production by dynamically adjusting process parameters (flow rates, residence times, mixing speeds, temperature profiles) based on the specific product and batch size requirements. Advanced process control algorithms automatically optimize parameters for each personalized medicine run, maintaining high efficiency despite variable production scales
3Manufacturing precision
If real-time monitoring and control adjustments are implemented, then process quality is improved, but system complexity increases
Solution Approach 1:
The patent implements self-regulating control systems where the manufacturing process automatically corrects deviations through integrated feedback loops without requiring constant operator intervention. The system monitors its own performance, detects anomalies, and adjusts process parameters autonomously, reducing the need for complex external monitoring infrastructure while maintaining high quality standards
Data Source
AI summary
The present disclosure relates to a method and system for monitoring a bio-pharmaceutical process, said bio-pharmaceutical process being controlled based on as set of instructions for controlling said biopharmaceutical process. The method comprises the following steps performed by a bio-pharmaceutical process monitoring element: obtaining (S11) said set of instructions for controlling the biopharmaceutical process, and while the instructions of the set of instructions for controlling the bio-pharmaceutical process are executed, for each executed instruction receiving (S13) an execution status update indicating which instruction is presently executed or has just been finished, and forming (S14) an execution status indication relating the instruction presently executed or just finished to its position in the set of instructions based on the received execution status update.